Navigation Links
Research!America Honors Univ. of Chicago Economists for Study Showing Economic Impact of HIV/AIDS Drug Development
Date:10/9/2007

WASHINGTON, Oct. 9 /PRNewswire-USNewswire/ -- Research!America today presented its 2007 Eugene Garfield Economic Impact of Medical and Health Research Award to two University of Chicago economists. Tomas Philipson, Ph.D., and Anupam Jena, Ph.D., were honored for their study "Who Benefits from New Medical Technologies?" published in Forum for Health Economics and Policy.

Using a novel approach, Philipson and Jena measure the value of HIV/AIDS drugs developed from 1980 to 2000. They calculate nearly $1.4 trillion in total value -- past and future -- to consumers from these drugs, based on the resulting gains in survival. They also estimate past and future profits for producers of the drugs to be nearly $63 billion -- or 5% of the total value. The authors conclude that such relatively low profits could reduce the incentive for producers to develop future HIV/AIDS treatments. They recommend exploring ways to raise the value to producers of new medical technologies in order to encourage further innovation.

Mark McClellan, MD, Ph.D., former Centers for Medicare and Medicaid Services administrator, and Eugene Garfield, Ph.D., the award benefactor, presented the award to Philipson and Jena today in Washington, DC. The award is named for Garfield, president and founding editor of The Scientist and creator of the Science Citation Index. McClellan headed the award selection committee. Both are Research!America board members.

Presenting the award, McClellan noted the contributions of past recipients and the need to build on their work.

"While the opportunity to understand and prevent disease and its complications has never been greater, the challenge for promoting effective, efficient use of increasingly diverse and sophisticated treatments has also never been greater," he said. "Expanding our knowledge of the economic impact of medical and health research will help overcome the challenges on the path to better health that we all know lies ahead."

Citing the importance of the Garfield Award in encouraging further study in this area, Mary Woolley, Research!America's president, said, "We need much more work like that of Dr. Philipson and Dr. Jena to show how important health-related research is for our nation's economy as well as our length and quality of life."

About the 2007 Recipients

Tomas Philipson, Ph.D., is a tenured professor in the Irving B. Harris Graduate School of Public Policy Studies at the University of Chicago. He is also a faculty member of the university's Department of Economics and its Law School. One of the nation's leading experts in the field of health economics, he has served as a senior economic adviser to the U.S. government.

Anupam Jena completed his Ph.D. in economics at the University of Chicago in 2006 as part of the University's Medical Scientist (MD/Ph.D.) Training Program. He is currently a third-year medical student at the University of Chicago and a Bing Center Visiting Fellow at the Rand Corporation. His research has focused on the economic value of medical innovation, implications of cost-effectiveness policies for technological growth and the economics of fertility.

About Research!America

Research!America is the nation's largest not-for-profit public education and advocacy alliance working to make research to improve health a higher national priority. Founded in 1989, Research!America is supported by more than 500 member organizations that represent the voices of more than 125 million Americans.

Ms. Woolley is available for further comment.


'/>"/>
SOURCE Research!America
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. US Academy honors 15 for major contributions to science
2. American Cancer Society Honors Exemplary Cancer Caregivers
3. Johns Hopkins Medicine Honors U.A.E. Sheikh Zayed Bin Sultan Al Nahyan
4. Baltimore is Americas Fittest City; Chicago the Fattest
5. Chicago :FDA imposes Ban on Biomedical Tissue Services
6. Chicago: Dad, I need you desperately, Please come back
7. Couples To Swap Kidneys In Chicago
8. Funds Allocated to Illinois and Chicago to Prepare in Case of a Flu Pandemic
9. Food Poisoning at the Chicago Food Festival
10. Rural Canadians travel far for specialists: study
11. A new study surpasses Gene Therapy Hurdle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... DDS, and Randall Markarian, DDS, are co-chairs for the Illinois State Dental Society ... Friday-Saturday, July 15-16 at the Gateway Convention Center in Collinsville. , ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... Foundation, a not-for-profit organization responsible for clinical transfusion research programs and for the ... the Pathogen Reduction Evaluation and Predictive Analytical Rating Score (PREPAReS) study. , ...
(Date:6/23/2016)... ... June 23, 2016 , ... SyncDog, Inc. ... mobile security software, is featured in the current issue of Silicon Review ... companies with innovative technology solutions and features them in their magazine. The magazine ...
(Date:6/23/2016)... Newark, NJ (PRWEB) , ... June 23, 2016 ... ... declared today’s Appellate Court ruling a victory for consumers seeking relief from the ... Div., Docket No. A2913-15T2 & A2929-15T2. , In their ruling ( ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... A key ... DC area, which is one of the best known examples of areas that lack ... amassed almost a thousand daily users. , Any participant within the marijuana industry, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Consumers have taken a more ... placed more emphasis on patient outcomes. ... in the pharmaceutical industry have evolved beyond just ... companies are focusing on becoming more patient-oriented across ... and services that improve health. ...
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, Inc., ... development and manufacturing of collagen and mineral based ... today that Bill Messer has joined ... to further leverage the growing portfolio of oral ... Bill joins the Collagen Matrix executive ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
Breaking Medicine Technology: